Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Surface Oncology Inc (NQ: SURF ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 7, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Surface Oncology Inc < Previous 1 2 3 Next > Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences August 31, 2023 Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting From Surface Oncology, Inc. Via GlobeNewswire SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF August 07, 2023 From Kahn Swick & Foti, LLC Via Business Wire Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023 August 02, 2023 From Surface Oncology, Inc. Via GlobeNewswire Health Care Company Coherus BioSciences Announces Merger With Surface Oncology June 16, 2023 Via Benzinga Recap: Surface Oncology Q1 Earnings May 04, 2023 Via Benzinga Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares July 27, 2023 Via Benzinga Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades July 11, 2023 Via Benzinga Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made June 28, 2023 Via Benzinga Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock June 24, 2023 Via Benzinga SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF June 21, 2023 From Kahn Swick & Foti, LLC Via Business Wire Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability June 20, 2023 Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on the shares of Coherus BioSciences, Inc. Via Benzinga Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June June 16, 2023 U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P... Via Benzinga Crude Oil Rises; Adobe Posts Upbeat Results June 16, 2023 U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 June 20, 2023 Via Benzinga Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday June 16, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording losses in today’s session. Coherus BioSciences, Inc. (NASDAQ: CHRS) tumbled 16.8%... Via Benzinga Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 16, 2023 Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781. Via Benzinga SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders June 16, 2023 From Halper Sadeh LLC Via Business Wire US Stocks Mixed; Dow Gains 50 Points June 16, 2023 U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 16, 2023 Via Benzinga Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M June 16, 2023 Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that Via Benzinga Coherus to Acquire Surface Oncology June 16, 2023 From Surface Oncology, Inc. Via GlobeNewswire Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023 May 04, 2023 From Surface Oncology, Inc. Via GlobeNewswire Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023 April 18, 2023 – New in vivo data show SRF114 promotes a pro-inflammatory tumor microenvironment resulting in robust antitumor activity in mouse models – From Surface Oncology, Inc. Via GlobeNewswire Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023 March 16, 2023 From Surface Oncology, Inc. Via GlobeNewswire Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022 March 09, 2023 From Surface Oncology, Inc. Via GlobeNewswire Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference February 28, 2023 From Surface Oncology, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session February 09, 2023 Via Benzinga Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference February 02, 2023 From Surface Oncology, Inc. Via GlobeNewswire The 3 Best Biotech Stocks Under $1 to Buy for January January 26, 2023 Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. Via InvestorPlace Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology January 09, 2023 Surface Oncology initiates clinical trial with antibody discovered using Vaccinex’s ActivMAb® Antibody Discovery Platform From Vaccinex, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
